Monopar Therapeutics
MNPR
#7537
Rank
NZ$0.85 B
Marketcap
NZ$126.13
Share price
-1.84%
Change (1 day)
-22.65%
Change (1 year)

EPS for Monopar Therapeutics (MNPR)

EPS in 2026 (TTM): NZ-$3.29

According to Monopar Therapeutics's latest financial reports the company's current EPS (TTM) is NZ-$3.49. In 2025 the company made an earnings per share (EPS) of NZ-$3.38 an increase over its 2024 EPS that were of NZ-$7.51.

EPS history for Monopar Therapeutics from 2016 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ-$3.29-2.59%
2025NZ-$3.38-54.99%
2024NZ-$7.5135.2%
2023NZ-$5.56-26.75%
2022NZ-$7.5913.7%
2021NZ-$6.6725.86%
2020NZ-$5.3028.89%
2019NZ-$4.1145.28%
2018NZ-$2.83-80.5%
2017NZ-$14.521296.33%
2016NZ-$1.04

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
ORIC Pharmaceuticals
ORIC
NZ-$2.47-29.32%๐Ÿ‡บ๐Ÿ‡ธ USA